Stopping Plavix Therapy Linked to Death or Heart Attack: "Patients suffering from acute coronary syndrome who stop taking clopidogrel (Plavix) may be more likely to die or to suffer an acute myocardial infarction especially in the first 90 days after cessation, researchers say.

Plavix, manufactured by Bristol-Myers Squibb Co. and Sanofi-Aventis SA, is an antiplatelet drug, which discourages the formation of blood clots and helps prevent heart attacks and strokes caused by clots."